Respiratory tract infections in children in developing countries

Miguel Cashat-Cruz1, José Juan Morales-Aguirre, Mónica Mendoza-Azpiri

  • 1Department of Epidemiology, Hospital Infantil de México Federico Gómez, Dr. Márquez # 162, Colonia Doctores, Delegación Cuauhtémoc, México, DF, México. mcashat@medscape.com <mcashat@medscape.com>

Insights

Acute respiratory infections, particularly pneumonia, are a major cause of child mortality in developing nations. Addressing risk factors and improving healthcare access are crucial for preventing deaths in young children.

Area of Science:

  • Global Health
  • Pediatrics
  • Infectious Diseases

Background:

  • Acute respiratory infections (ARIs) are a leading cause of global morbidity.
  • Pneumonia is a primary cause of mortality in children under five in developing countries.
  • Factors like poverty, malnutrition, and the HIV/AIDS pandemic exacerbate ARI burden.

Purpose of the Study:

  • To highlight the significance of ARIs and pneumonia in developing countries.
  • To emphasize the challenges in diagnosing and treating these conditions in resource-limited settings.
  • To underscore the need for improved healthcare strategies and international support.

Main Methods:

  • Review of risk factors associated with respiratory infections in developing countries.
  • Discussion of diagnostic approaches recommended by the World Health Organization (WHO).
  • Emphasis on the role of primary healthcare workers in diagnosis and treatment.

Main Results:

  • Multiple socioeconomic and health factors contribute to ARI prevalence.
  • Clinical parameters are recommended for pneumonia diagnosis due to etiological identification difficulties.
  • Primary healthcare plays a vital role in reducing mortality.

Conclusions:

  • Effective management of ARIs, especially pneumonia, requires addressing multifactorial risks.
  • Strengthening primary healthcare systems in rural areas is essential.
  • International collaboration and economic support are vital for improving healthcare and research benefits in developing nations.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...